| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/12/1995 | EP0647713A1 Peptidyl prolyl-cis.trans-isomerase |
| 04/12/1995 | EP0647712A1 Production of S-adenosyl-methionine (SAM) by fermentation of transformed bacteria |
| 04/12/1995 | EP0647711A1 Plants transformed with a DNA sequence from bacillus thuringiensis lethal to lepidoptera |
| 04/12/1995 | EP0647710A1 Novel protease |
| 04/12/1995 | EP0647395A2 Mice deficient in neurotrophin receptors |
| 04/12/1995 | EP0647280A1 Over expression of single-stranded molecules |
| 04/12/1995 | EP0647278A1 Method and system for molecular-biological diagnostics |
| 04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
| 04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 04/12/1995 | EP0647274A1 Recombinant baculoviruses containing insect cellular promoter |
| 04/12/1995 | EP0647273A1 Dna sequences encoding oligosaccharide transporter |
| 04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 04/12/1995 | EP0647271A1 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647269A1 Dna isolation method |
| 04/12/1995 | EP0647268A1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647232A1 Deproteinization with azlactone-functional supports |
| 04/12/1995 | EP0647140A1 Papillomavirus vaccines |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0647138A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 04/12/1995 | EP0567554B1 Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
| 04/12/1995 | EP0478696B1 Efficient method for identifiable expression of non-selectable genes |
| 04/12/1995 | EP0473693B1 Target-dependent synthesis of a replicatable rna |
| 04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
| 04/12/1995 | EP0357672B1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
| 04/12/1995 | EP0214971B1 Yeast strains producing cellulolytic enzymes and methods and means for constructing them |
| 04/11/1995 | US5405951 Using water soluble organic solvents eliminates the use of caustic and poisonous compositions such as chaotropes |
| 04/11/1995 | US5405946 Anticoagulants |
| 04/11/1995 | US5405945 DNA encoding reproductive hormones and expression using a minigene |
| 04/11/1995 | US5405942 Prepro insulin-like growth factors I and II |
| 04/11/1995 | US5405941 Gene therapy; anticancer, antiinflammatory agents, autoimmune diseases, Alzheimers*s |
| 04/11/1995 | US5405777 Acetic acid assimilating gene and a method for preventing accumulation of acetic acid in culture medium |
| 04/11/1995 | US5405776 Genetic engineering |
| 04/11/1995 | US5405775 A multicopy single-stranded DNA (msDNA) synthesizing system in Escherichia coli |
| 04/11/1995 | US5405774 DNA encoding a mutated thermostable nucleic acid polymerase enzyme from thermus species sps17 |
| 04/11/1995 | US5405771 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/11/1995 | US5405768 Genetic engineering |
| 04/11/1995 | US5405765 Method for the production of transgenic wheat plants |
| 04/11/1995 | US5405763 A polynucleotides from ARTHROBACTER capable geneic engineering to produce a hydrolases enzyme for hydrolysing a racemic ester of chrysanthemic acid to form a trans acid |
| 04/11/1995 | US5405760 Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
| 04/11/1995 | US5405746 Method of sequencing DNA |
| 04/11/1995 | CA1335182C Cellulose binding fusion proteins |
| 04/11/1995 | CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies |
| 04/06/1995 | WO1995009365A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | WO1995009248A1 Methods and compositions for efficient nucleic acid sequencing |
| 04/06/1995 | WO1995009242A1 Production of novel carbohydrate with improved plastid initial |
| 04/06/1995 | WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 04/06/1995 | WO1995009239A2 Production, purification, cleavage and use of fusion peptides |
| 04/06/1995 | WO1995009238A1 High level expression of human cyclooxygenase-2 |
| 04/06/1995 | WO1995009237A2 Expression of human d4 dopamine receptors in stable cell lines |
| 04/06/1995 | WO1995009236A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY |
| 04/06/1995 | WO1995009233A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
| 04/06/1995 | WO1995009231A1 Insulin-secreting cell lines, methods of production and use |
| 04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 04/06/1995 | WO1995009182A1 Protective antigens against parasites |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009010A1 Arteriosclerosis remedy |
| 04/06/1995 | WO1995009009A1 Polyamino acid oligonucleotide carrier |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995008914A1 Transgenic cotton plants producing heterologous peroxidase |
| 04/06/1995 | WO1995007466A3 Biotin-analog conjugated antibodies for positive cell selection and release |
| 04/06/1995 | WO1995007345A3 Identification of alleles of tandem repeats by hybridization |
| 04/06/1995 | WO1995006744A3 Methods of suppressing immune response by gene therapy |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | WO1995006717A3 Methods of suppressing graft rejection |
| 04/06/1995 | WO1995003427A3 Oligonucleotide screening assay |
| 04/06/1995 | WO1995003417A3 Homologously recombinant slow growing mycobacteria and uses therefor |
| 04/06/1995 | CA2172997A1 Insulin-secreting cell lines, methods of production and use |
| 04/06/1995 | CA2172978A1 Arteriosclerosis remedy |
| 04/06/1995 | CA2172961A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/06/1995 | CA2172611A1 High level expression of human cyclooxygenase-2 |
| 04/06/1995 | CA2172547A1 Expression of human d4 dopamine receptors in stable cell lines |
| 04/06/1995 | CA2172492A1 Protective antigens against parasites |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology |
| 04/06/1995 | CA2170986A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/05/1995 | EP0646883A1 Gene database retrieval system |
| 04/05/1995 | EP0646646A2 Protein expression system |
| 04/05/1995 | EP0646645A2 A process for producing a substance |
| 04/05/1995 | EP0646644A2 Periplasmic membrane-bound system for detecting protein-protein interactions |
| 04/05/1995 | EP0646643A1 Modified human granulocyte macrophage-colony stimulating factor gene and expression thereof in yeast |
| 04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
| 04/05/1995 | EP0646181A1 Use of nucleic acid analogues in the inhibition of nucleic acid amplification. |
| 04/05/1995 | EP0646180A1 Methods for inactivating nucleotide sequences and metal chelates for use therein |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646177A1 HETEROLOGOUS GENE EXPRESSION IN $i(BACILLUS SUBTILIS): FUSION APPROACH |
| 04/05/1995 | EP0646176A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
| 04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
| 04/05/1995 | EP0646173A1 Reagent for agglutination assays |